These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pyrimidine salvage enzymes in human tonsil lymphocytes: II. Purification and properties of deoxycytidine kinase. Szyfter K, Sasvári-Székely M, Spasokukotskaja T, Antoni F, Staub M. Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):173-82. PubMed ID: 3019066 [Abstract] [Full Text] [Related]
6. Nucleotide specificity of human deoxycytidine kinase. Shewach DS, Reynolds KK, Hertel L. Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603 [Abstract] [Full Text] [Related]
7. Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosides. Sarup JC, Fridland A. Biochemistry; 1987 Jan 27; 26(2):590-7. PubMed ID: 3030413 [Abstract] [Full Text] [Related]
12. Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase. Datta NS, Shewach DS, Mitchell BS, Fox IH. J Biol Chem; 1989 Jun 05; 264(16):9359-64. PubMed ID: 2542307 [Abstract] [Full Text] [Related]
13. Reversible permeabilization of lymphocytes destroys the incorporation of deoxythymidine but not of deoxycytidine. Taljanidisz J, Sasvari-Szekely M, Spasokutotskaja T, Antoni F, Staub M. Biochim Biophys Acta; 1986 Mar 14; 885(3):266-71. PubMed ID: 3947681 [Abstract] [Full Text] [Related]
14. Human deoxycytidine kinase: kinetic mechanism and end product regulation. Kim MY, Ives DH. Biochemistry; 1989 Nov 14; 28(23):9043-7. PubMed ID: 2557916 [Abstract] [Full Text] [Related]